PAIRX BIO PTE. LTD.
Country of registration | Singapore |
Registration number | 202012784G |
Local SIC | |
Incorporation date | 4 May 2020 |
Company age | 6 years |
Official entity type | Private Limited Company |
No. of officers | 20 |
Contact
21 BIOPOLIS ROAD, #02-03, NUCLEOS, Singapore 138567
This is the legal entity page of PAIRX BIO PTE. LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- PAIRX BIOView MoreSingaporePairX Bio is a life sciences company focused on developing next-generation cancer immunotherapies based on mRNA splicing biology. Our platform validates tumor-associated antigens and T cells in multiple patient-derived tumors simultaneously, leveraging proprietary antigen and T cell validation methods. Founded by Dr. David Epstein at Duke-NUS Medical School and incubated by EVX Ventures, we have secured funding from leading investors EVX Ventures and Avendesora. For more information, please visit pairxbio.com.
Revenue | 1 - 10m |
Share Capital - Preference shares | SGD 13,219,737 |
Share Capital - Ordinary shares | SGD 3,720 |
Frequently Asked Questions (FAQ)
- What is the address of PAIRX BIO PTE. LTD.?
- Where is PAIRX BIO PTE. LTD.'s headquarter?
- What is PAIRX BIO PTE. LTD.'s contact number?
- What PAIRX BIO PTE. LTD.'s spending power?
- Does PAIRX BIO PTE. LTD. have a presence in the domain it operates in?

